Why the study?
Does valsartan improve blood pressure reduction and response rate compared to losartan and placebo in adults with uncomplicated essential hypertension?
Does valsartan improve blood pressure reduction and response rate compared to losartan and placebo in adults with uncomplicated essential hypertension?
Valsartan 80/160 mg is as effective as losartan 50/100 mg in reducing blood pressure but yields a significantly higher responder rate at 8 weeks in patients with mild to moderate essential hypertension.
Answers are grounded in this paper and cite their sources.
May support preferring valsartan over losartan for higher response rates; extends head-to-head ARB data in essential hypertension.
We compared the angiotensin II receptor antagonist valsartan to losartan as an antihypertensive agent in an 8-week trial. Adults with uncomplicated essential hypertension (baseline seated diastolic blood pressure < 115 mm Hg and > or = 95 mm Hg) were randomized to receive 80 mg valsartan, 50 mg losartan, or placebo once daily. After 4 weeks doses of active medication and placebo were doubled. Seated systolic and diastolic blood pressures were measured and the response rate evaluated. Tolerability was assessed by the incidence of adverse events. Both angiotensin II receptor antagonists produced similar significant reductions in mean blood pressures at 4 and 8 weeks compared to placebo. Valsartan produced a significantly higher number of responders (62%) than losartan (55%, P = .02) at the 8 week treatment endpoint. The incidence of adverse experiences (AE) was similar in all three groups, with headache and dizziness reported most often. Valsartan (80/160 mg) monotherapy in this trial was as effective and well tolerated as 50/100 mg losartan in treating mild to moderate essential hypertension, and at 160 mg has a significantly higher responder rate than 100 mg losartan.
No takes yet. Share an insight, caveat, or question.
Thomas Hedner (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: